Insider Trading Activity MyoKardia, Inc. (NASDAQ:MYOK) – Insider Sold 32,988 shares of Stock

ME Staff
-
0

Insider Trading Activity For MyoKardia, Inc. (NASDAQ:MYOK)

Anastasios Gianakakos , Insider of MyoKardia, Inc. (NASDAQ:MYOK) reportedly Sold 32,988 shares of the company’s stock at an average price of 15 for a total transaction amount of $494,820.00 SEC Form

Insider Trading History For MyoKardia, Inc. (NASDAQ:MYOK)

  • On 11/3/2015 Sanofi, Major Shareholder, bought 900,000 with an average share price of $10.00 per share and the total transaction amounting to $9,000,000.00.View SEC Filing
  • On 11/3/2015 Mark L Perry, Director, bought 5,000 with an average share price of $10.00 per share and the total transaction amounting to $50,000.00.View SEC Filing
  • On 11/3/2015 Jonathan C Fox, Insider, bought 3,000 with an average share price of $10.00 per share and the total transaction amounting to $30,000.00.View SEC Filing
  • On 11/3/2015 Anastasios Gianakakos, CEO, bought 1,350 with an average share price of $10.00 per share and the total transaction amounting to $13,500.00.View SEC Filing
  • On 10/3/2016 Sanofi, Major Shareholder, bought 450,000 with an average share price of $15.00 per share and the total transaction amounting to $6,750,000.00.View SEC Filing
  • On 3/20/2017 Jake Bauer, Insider, sold 667 with an average share price of $15.00 per share and the total transaction amounting to $10,005.00.View SEC Filing
  • On 3/20/2017 Anastasios Gianakakos, CEO, sold 1,412 with an average share price of $15.00 per share and the total transaction amounting to $21,180.00.View SEC Filing

    • Analyst Ratings For MyoKardia, Inc. (NASDAQ:MYOK)
    These are 4 Buy Ratings .
    The current consensus rating for MyoKardia, Inc. (NASDAQ:MYOK) is Buy (Score: 3.00) with a consensus target price of $28.00 , a potential (78.34% upside)

    Analyst Ratings History For MyoKardia, Inc. (NASDAQ:MYOK)

    • On 7/12/2016 Credit Suisse Group Reiterated Rating Buy with a price target of $16.00 to $20.00
    • On 9/22/2016 Wells Fargo & Company Reiterated Rating Buy
    • On 11/8/2016 Cowen and Company Reiterated Rating Buy with a price target of $28.00
    • On 3/13/2017 Wedbush Reiterated Rating Outperform with a price target of $24.00
    • On 5/10/2017 BMO Capital Markets Reiterated Rating Outperform with a price target of $32.00

    Recent Trading Activity for MyoKardia, Inc. (NASDAQ:MYOK)
    Shares of MyoKardia, Inc. closed the previous trading session at 15.70 down -0.25 -1.57% with 190,128 shares trading hands.